{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:13:30Z","timestamp":1776755610820,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T00:00:00Z","timestamp":1266019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s12185-010-0520-1","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T04:51:18Z","timestamp":1265950278000},"page":"392-400","source":"Crossref","is-referenced-by-count":26,"title":["Pluripotent stem cells as source of dendritic cells for immune therapy"],"prefix":"10.1007","volume":"91","author":[{"given":"Satoru","family":"Senju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Fukuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetake","family":"Matsuyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,13]]},"reference":[{"key":"520_CR1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.8066449","volume":"265","author":"T Nakano","year":"1994","unstructured":"Nakano T, Kodama H, Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science. 1994;265:1098\u2013101.","journal-title":"Science"},{"key":"520_CR2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0960-9822(00)00824-1","volume":"10","author":"PJ Fairchild","year":"2000","unstructured":"Fairchild PJ, Brook FA, Gardner RL, et al. Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr Biol. 2000;10:1515\u20138.","journal-title":"Curr Biol"},{"key":"520_CR3","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1182\/blood-2002-07-2254","volume":"101","author":"S Senju","year":"2003","unstructured":"Senju S, Hirata S, Matsuyoshi H, et al. Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells. Blood. 2003;101:3501\u20138.","journal-title":"Blood"},{"key":"520_CR4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.172.2.776","volume":"172","author":"H Matsuyoshi","year":"2004","unstructured":"Matsuyoshi H, Senju S, Hirata S, et al. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination. J Immunol. 2004;172:776\u201386.","journal-title":"J Immunol"},{"key":"520_CR5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1349-7006.2005.00123.x","volume":"96","author":"H Matsuyoshi","year":"2005","unstructured":"Matsuyoshi H, Hirata S, Yoshitake Y, et al. Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC\/CCL21 along with tumor antigen against peritoneally disseminated tumor cells. Cancer Sci. 2005;96:889\u201396.","journal-title":"Cancer Sci"},{"key":"520_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbrc.2005.06.096","volume":"335","author":"D Fukuma","year":"2005","unstructured":"Fukuma D, Matsuyoshi H, Hirata S, et al. Cancer prevention with semi-allogeneic ES cell-derived dendritic cells. Biochem Biophys Res Commun. 2005;335:5\u201313.","journal-title":"Biochem Biophys Res Commun"},{"key":"520_CR7","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1158\/0008-5472.CAN-05-2090","volume":"66","author":"Y Motomura","year":"2006","unstructured":"Motomura Y, Senju S, Nakatsura T, et al. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10. Cancer Res. 2006;66:2414\u201322.","journal-title":"Cancer Res"},{"key":"520_CR8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CJI.0b013e318194b63b","volume":"32","author":"S Fukushima","year":"2009","unstructured":"Fukushima S, Hirata S, Motomura Y, et al. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells. J Immunother. 2009;32:219\u201331.","journal-title":"J Immunother"},{"key":"520_CR9","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.181.9.6635","volume":"181","author":"Y Matsunaga","year":"2008","unstructured":"Matsunaga Y, Fukuma D, Hirata S, et al. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells. J Immunol. 2008;181:6635\u201343.","journal-title":"J Immunol"},{"key":"520_CR10","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.4049\/jimmunol.174.4.1888","volume":"174","author":"S Hirata","year":"2005","unstructured":"Hirata S, Senju S, Matsuyoshi H, et al. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. J Immunol. 2005;174:1888\u201397.","journal-title":"J Immunol"},{"key":"520_CR11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.4049\/jimmunol.178.2.918","volume":"178","author":"S Hirata","year":"2007","unstructured":"Hirata S, Matsuyoshi H, Fukuma D, et al. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. J Immunol. 2007;178:918\u201325.","journal-title":"J Immunol"},{"key":"520_CR12","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1634\/stemcells.2007-0321","volume":"25","author":"S Senju","year":"2007","unstructured":"Senju S, Suemori H, Zembutsu H, et al. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Stem Cells. 2007;25:2720\u20139.","journal-title":"Stem Cells"},{"key":"520_CR13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0198-8859(98)00058-5","volume":"59","author":"S Fujii","year":"1998","unstructured":"Fujii S, Senju S, Chen YZ, et al. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells. Hum Immunol. 1998;59:607\u201314.","journal-title":"Hum Immunol"},{"key":"520_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.it.2006.02.001","volume":"27","author":"T Okazaki","year":"2006","unstructured":"Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 2006;27:195\u2013201.","journal-title":"Trends Immunol"},{"key":"520_CR15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(04)16629-4","volume":"364","author":"X Zhan","year":"2004","unstructured":"Zhan X, Dravid G, Ye Z, et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet. 2004;364:163\u201371.","journal-title":"Lancet"},{"key":"520_CR16","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1158\/1078-0432.CCR-08-0309","volume":"14","author":"Z Su","year":"2008","unstructured":"Su Z, Frye C, Bae KM, et al. Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions. Clin Cancer Res. 2008;14:6207\u201317.","journal-title":"Clin Cancer Res"},{"key":"520_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2217\/rme.09.25","volume":"4","author":"SY Tseng","year":"2009","unstructured":"Tseng SY, Nishimoto KP, Silk KM, et al. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells. Regen Med. 2009;4:513\u201326.","journal-title":"Regen Med"},{"key":"520_CR18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/dvdy.1191","volume":"222","author":"H Suemori","year":"2001","unstructured":"Suemori H, Tada T, Torii R, et al. Establishment of embryonic stem cell lines from cynomolgus monkey blastocysts produced by IVF or ICSI. Dev Dyn. 2001;222:273\u20139.","journal-title":"Dev Dyn"},{"key":"520_CR19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bbrc.2006.04.135","volume":"345","author":"H Suemori","year":"2006","unstructured":"Suemori H, Yasuchika K, Hasegawa K, et al. Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun. 2006;345:926\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"520_CR20","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.4049\/jimmunol.176.5.2924","volume":"176","author":"II Slukvin","year":"2006","unstructured":"Slukvin II, Vodyanik MA, Thomson JA, et al. Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J Immunol. 2006;176:2924\u201332.","journal-title":"J Immunol"},{"key":"520_CR21","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1172\/JCI38591","volume":"119","author":"KD Choi","year":"2009","unstructured":"Choi KD, Vodyanik MA, Slukvin II. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors. J Clin Invest. 2009;119:2818\u201329.","journal-title":"J Clin Invest"},{"key":"520_CR22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0198-8859(98)00050-0","volume":"59","author":"H Tabata","year":"1998","unstructured":"Tabata H, Kanai T, Yoshizumi H, et al. Characterization of self-glutamic acid decarboxylase 65-reactive CD4+ T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus. Hum Immunol. 1998;59:549\u201360.","journal-title":"Hum Immunol"},{"key":"520_CR23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"520_CR24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature05934","volume":"448","author":"K Okita","year":"2007","unstructured":"Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313\u20137.","journal-title":"Nature"},{"key":"520_CR25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"520_CR26","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/stem.33","volume":"27","author":"S Senju","year":"2009","unstructured":"Senju S, Haruta M, Matsunaga Y, et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells. 2009;27:1021\u201331.","journal-title":"Stem Cells"},{"key":"520_CR27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nbt0708-739","volume":"26","author":"N Nakatsuji","year":"2008","unstructured":"Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nat Biotechnol. 2008;26:739\u201340.","journal-title":"Nat Biotechnol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0520-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-010-0520-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-010-0520-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:31Z","timestamp":1559451691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-010-0520-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,13]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["520"],"URL":"https:\/\/doi.org\/10.1007\/s12185-010-0520-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,13]]}}}